Rebuttal from Dr Jiménez
Chest
.
2013 Feb 1;143(2):302-303.
doi: 10.1378/chest.12-2448.
Author
David Jiménez
1
Affiliation
1
Respiratory Department, Ramón y Cajal Hospital, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain. Electronic address: djc_69_98@yahoo.com.
PMID:
23381311
DOI:
10.1378/chest.12-2448
No abstract available
Publication types
Editorial
Comment
MeSH terms
Contraindications
Fibrinolytic Agents*
Humans
Pulmonary Embolism / drug therapy*
Thrombolytic Therapy / trends*
Substances
Fibrinolytic Agents